Fig. 1 · Structure
Documents & Downloads
IQA
CK2 Inhibitor
IQA is a potent and selective inhibitor of protein kinase CK2, a serine/threonine kinase involved in various cellular processes. By specifically inhibiting CK2 activity, IQA has potential applications in cancer research and therapeutic development, particularly in studies focusing on cell proliferation and survival. Its selectivity offers valuable insights into the role of CK2 in oncogenic signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 391670-48-7 |
| Applications | CK2 Inhibitor |
| Formula | C17H12N2O3 |
| Molecular Weight | 292.29 |
| Synonyms | CGP-029482 |
| SMILES | O=C(O)CC(C1=C2C=CC=C1)=C(N3)N2C4=C(C=CC=C4)C3=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.